Concepedia

Publication | Closed Access

Earlier use of androgen receptor‐axis‐targeted drugs may improve overall survival in patients with non‐metastatic castration‐resistant prostate cancer

DOI

11

Citations

18

References

2018

Year

Keiichiro Mori, Takahiro Kimura, Kagenori Ito, Hajime Onuma, Masatoshi Tanaka, Taishi Matsuura, Gaku Kurokawa, Kosuke Iwatani, Yuzo Inaba, Keigo Sakanaka,
The Prostate

Abstract

Early use of ARAT may improve OS, PFS, and PSA response in CRPC. Larger, prospective studies will be required to confirm our findings.

References

YearCitations

Page 1